Antibiofilm and Immune-Modulatory Activity of Cannabidiol and Cannabigerol in Oral Environments—In Vitro Study

Autores organización

• David Augusto Diaz Baez

  Autor

Autores

• Garzón H.S.
• Loaiza-Oliva M.
• Martínez-Pabón M.C.
• Puerta-Suárez J.
• Téllez Corral M.A.
• Bueno-Silva B.
• Suárez D.R.
• Suárez L.J.

Unidades de investigación

• Unidad de Investigación Básica Oral UIBO

  

  Investigador

  Gloria Ines Lafaurie Villamil

Resumen

Resumen no disponible

Keywords

• antimicrobial agents; cannabidiol; cannabigerol; cannabinoids; immunomodulation; oral biofilms; periodontitis;amphotericin B; cannabidiol; cannabigerol; chlorhexidine; fluconazole; gamma interferon; gamma interferon inducible protein 10; interleukin 10; interleukin 17; interleukin 1beta; interleukin 4; interleukin 6; interleukin 8; monocyte chemotactic protein 1; superoxide dismutase; transforming growth factor beta; Actinomyces naeslundii; antibiofilm activity; antiinflammatory activity; antimicrobial activity; Article; bacterial growth; biofilm; Candida albicans; cell viability; cytotoxicity; fibroblast; flow cytometry; Fusobacterium nucleatum; high performance liquid chromatography; immunomodulation; in vitro study; microbial community; minimum inhibitory concentration; nonhuman; periodontal ligament; periodontitis; plankton; Propionibacterium acnes; Streptococcus mitis; Streptococcus mutans; Streptococcus oralis; Tannerella forsythia; Treponema denticola